FeesSafety
Pluang+

Injective (INJ) price jumps 24% amid strong exchange outflows and institutional adoption.

Technical Signals
16 Oct 2026, 06:55 WIB
Coincu
View Source
Bullish
Injective (INJ) price jumps 24% amid strong exchange outflows and institutional adoption.

Injective (INJ) surged 24.46% to $9.13 on October 16, 2026, driven by sustained token withdrawals from exchanges and a major institutional data migration by Pineapple Financial. Despite high reported trading volumes, much of the on-chain activity is wash trading, so genuine liquidity is lower than it appears. The price rally is supported by net outflows from centralized exchanges over 10 of the past 14 days, indicating accumulation rather than selling. Investors should watch if the largest accumulator wallet begins selling or if outflows continue, as these will signal the rally's sustainability.

Injective (INJ) is trading at Rp165.999 on Pluang as of October 16, 2026, 11:02 WIB, showing a 25.76% gain in one day, slightly above the article's reported 24.46% surge in USD. This strong performance contrasts with the typical Pluang order activity for INJ, where 79% are sell orders and only 21% are buy orders, suggesting that despite the price rally, many traders are taking profits. The circulating supply is fully in the market at 100 million tokens, supporting the liquidity dynamics discussed in the news.

More News (INJ)

Ripple transfers 126.8M XRP at zero book value; Injective halts Nov 24; Anthropic IPO priced at $83.

Ripple transfers 126.8M XRP at zero book value; Injective halts Nov 24; Anthropic IPO priced at $83.

Ripple transferred 126,791,458 XRP to a related entity at a zero carrying value, reflecting an accounting move, not a sale. Injective's blockchain will halt at block height 193,145,000 on Nov 24 for a software upgrade aimed at institutional features....

Market News
Neutral
2 days ago
Injective's Veyra mainnet upgrade passes with 99.51% approval, launching Nov 24 with new asset and privacy features.

Injective's Veyra mainnet upgrade passes with 99.51% approval, launching Nov 24 with new asset and privacy features.

Injective's Veyra mainnet upgrade has been approved by 99.51% of INJ stakers and is set to launch on November 24. The upgrade introduces support for real-world assets, enhanced privacy via CypherOS, request-for-quote perpetual contracts, and expanded...

Protocol Fundamentals
Bullish
3 days ago
Injective's Veyra upgrade passes with 99.51% support, enhancing institutional features and cross-chain tools.

Injective's Veyra upgrade passes with 99.51% support, enhancing institutional features and cross-chain tools.

Injective stakers overwhelmingly approved the Veyra mainnet upgrade with 99.51% support, set to activate on November 24, 2026. This upgrade focuses on institutional users by improving real-world asset infrastructure, adding request-for-quote trading ...

Protocol Fundamentals
Bullish
3 days ago
Injective launches new whitepaper and first U.S.-listed ETF offering direct INJ token exposure with staking rewards.

Injective launches new whitepaper and first U.S.-listed ETF offering direct INJ token exposure with staking rewards.

Injective has released a new whitepaper detailing its blockchain infrastructure for real-world assets, decentralized trading, and AI applications, marking its evolution into an independent Layer-1 blockchain. Concurrently, the Canary Staked INJ ETF b...

Protocol Fundamentals
Bullish
3 days ago
Injective rises 13% after partnership with University of Tokyo and SEC transfer-agent registration news

Injective rises 13% after partnership with University of Tokyo and SEC transfer-agent registration news

Injective (INJ) saw a 13% price increase following two key developments: a new partnership with the University of Tokyo's Endowed Chair for Blockchain Innovation and renewed attention on its affiliate's SEC registration as a transfer agent. The partn...

Market News
Bullish
4 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App